Finally, this important effect on headache may be related to the tumor expression of a truncated somatostatin receptor 5 variant, as described in two cases of patients with severe headaches and no biochemical effects of octreotide, but a good response to Pas-LAR (20). The gene discussed is SSTR5; the disease is neoplasm.